Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Neoplasm Metastasis 6Neoplasms 4Carcinoma, Squamous Cell 4Squamous Cell Carcinoma of Head and Neck 3Lung Neoplasms 3Brain Neoplasms 3Recurrence 2Head and Neck Neoplasms 2Glioblastoma 2Carcinoma 2Triple Negative Breast Neoplasms 1Thrombocytosis 1Skin Squamous Cell Cancer 1Rare Tumor 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Penile Neoplasms 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1NSCLC 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Cisplatin 30Magnetic Resonance Spectroscopy 21Radiotherapy 20pembrolizumab 18Specimen Handling 17Cetuximab 16Radiotherapy, Intensity-Modulated 11Paclitaxel 11Carboplatin 11Fluorouracil 10Biopsy 101,2-diaminocyclohexaneplatinum II citrate 10Radiation 9Platinum 9Drug Therapy 9Taxes 7Surgical Procedures, Operative 7Celecoxib 7X-Rays 6Standard of Care 6Sentinel Lymph Node Biopsy 6Surveys and Questionnaires 5Nivolumab 5cemiplimab 4Metformin 4Fluorodeoxyglucose F18 4Docetaxel 4Chemoradiotherapy 4(225)Ac-DOTA-c(RGDyK) 4durvalumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Mouth Neoplasms × dacomitinib × Clear all
NCT01116843 2015-07-10

Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment

University Health Network, Toronto

Phase 1/2 Completed
13 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡